Sliwiński Paweł
II Klinika Chorób Płuc i Zakład Diagnostyki i Leczenia Niewydolności Oddychania, Instytut Gruźlicy i Chorób Płuc w Warszawie.
Pol Merkur Lekarski. 2004 May;16 Suppl 1:57-61.
Results of clinical studies conducted in patients with chronic obstructive pulmonary disease (COPD) in recent years have pointed out at new perspectives in the management of COPD. They include both pharmacological and non-pharmacological methods. Progress in pharmacological therapy results mainly due to introduction of long acting anticholinergic compound and combined therapy with long acting beta2-agonists and inhaled corticosteroids. Non-invasive positive pressure ventilation (NIPPV) appears to play a significant role in the treatment of severe COPD exacerbations. Also pulmonary rehabilitation has found very important position in the management of COPD patients. However, from patients' perspective the most important benefit resulting from new therapies is an improvement in health related quality of life.
近年来针对慢性阻塞性肺疾病（COPD）患者开展的临床研究结果指出了COPD管理的新视角。这些视角包括药理学和非药理学方法。药理学治疗的进展主要归功于长效抗胆碱能化合物的引入以及长效β2受体激动剂与吸入性糖皮质激素的联合治疗。无创正压通气（NIPPV）在重度COPD加重期的治疗中似乎发挥着重要作用。此外，肺康复在COPD患者的管理中也占据了非常重要的地位。然而，从患者的角度来看，新疗法带来的最重要益处是健康相关生活质量的改善。
